Buying health care services directly online offers convenience but also risks if patients don’t tell their regular doctor or provider. Poll looks at older adults’ use and attitudes.

Surgery patients who drink at a risky level have higher risks of complications; surgical teams could use artificial intelligence to search their records for signs that they may need to cut back.

Physician in training inspired to specialize in neurosurgery after losing his father to brain cancer, continues to raise funds for glioblastoma research

Researchers and clinicians at the U-M Health Frankel Cardiovascular Center began sending reconditioned pacemakers to low- and middle-income countries for compassionate use cases in 2010 through the “My Heart Your Heart” program.

A recent study from U-M offers more insight into the underlying causes of EOE.

Vaccination against the coronavirus was much lower in adults and children with sickle cell disease despite a higher risk of severe COVID-19.

The Flourish recharge room, an innovative gift given to Michigan Medicine, provides staff with a transformative and healing experience.

Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment, also finding a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.

Investigators found that people with obesity who underwent bariatric surgery had stable cognition two years later. Researchers say it suggests that bariatric surgery may mitigate the natural history of cognitive decline expected in people with obesity.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

Babies born with sickle cell disease face social inequality as well as a lifelong chronic disease that is often undertreated with proven drugs.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Jourdan Triebwasser, M.D., medical director of the University of Michigan Health Von Voigtlander Women's Hospital Birth Center and a maternal-fetal medicine specialist with a particular interest in this condition, shares more about detecting and treating the condition, and the importance of multidisciplinary collaboration in maternal-fetal outcomes.

At Michigan Medicine, a mother of eight kids underwent a heart transplant surgery through a process called donation after circulatory death, or DCD, which saved her life.